Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.

Beigel, John H; Tomashek, Kay M; Dodd, Lori E

Beigel, John H; Tomashek, Kay M; Dodd, Lori E.

Affiliation

Beigel JH; National Institute of Allergy and Infectious Diseases, Bethesda, MD jbeigel@niaid.nih.gov.
Tomashek KM; National Institute of Allergy and Infectious Diseases, Bethesda, MD jbeigel@niaid.nih.gov.
Dodd LE; National Institute of Allergy and Infectious Diseases, Bethesda, MD jbeigel@niaid.nih.gov.

N Engl J Med ; 383(10): 994, 2020 09 03.

Article in En | MEDLINE | ID: mdl-32649078

Subject(s)

Betacoronavirus; Coronavirus Infections; Pandemics; Pneumonia, Viral; Adenosine Monophosphate/analogs & derivatives; Alanine/analogs & derivatives; COVID-19; Coronavirus Infections/drug therapy; Humans; SARS-CoV-2; COVID-19 Drug Treatment

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Pandemics / Betacoronavirus Limits: Humans Language: En Journal: N Engl J Med Year: 2020 Type: Article Affiliation country: Moldova

Fulltext

XML

PubMed Links

Search on Google